Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gaurav Kumar Pandey

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Cell Cycle (Georgetown, Tex.)|December 9, 2014
Temporal separation of replication and transcription during S-phase progressionMatthieu Meryet-Figuiere, Babak Alaei-Mahabadi, Mohamad Moustafa Ali, et al.
Cancer Research Communications|December 6, 2023
Combined Inhibition of EZH2 and FGFR is Synergistic in BAP1-deficient Malignant MesotheliomaJitendra Badhai, Nick Landman, Gaurav Kumar Pandey, et al.
Cell Reports. Medicine|January 19, 2023
Genetic screens reveal new targetable vulnerabilities in BAP1-deficient mesotheliomaGaurav Kumar Pandey, Nick Landman, Hannah K Neikes, et al.
The Journal of Experimental Medicine|April 10, 2020
Combined deletion of Bap1, Nf2, and Cdkn2ab causes rapid onset of malignant mesothelioma in miceJitendra Badhai, Gaurav Kumar Pandey, Ji-Ying Song, et al.
Cancer Cell|December 18, 2014
The risk-associated long noncoding RNA NBAT-1 controls neuroblastoma progression by regulating cell proliferation and neuronal differentiationGaurav Kumar Pandey, Sanhita Mitra, Santhilal Subhash, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2019
EZH2 Is Overexpressed in <i>BRCA1</i>-like Breast Tumors and Predictive for Sensitivity to High-Dose Platinum-Based ChemotherapyJulian Puppe, Mark Opdam, Philip C Schouten, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Cell Cycle (Georgetown, Tex.)|December 9, 2014
Temporal separation of replication and transcription during S-phase progressionMatthieu Meryet-Figuiere, Babak Alaei-Mahabadi, Mohamad Moustafa Ali, et al.
Cancer Research Communications|December 6, 2023
Combined Inhibition of EZH2 and FGFR is Synergistic in BAP1-deficient Malignant MesotheliomaJitendra Badhai, Nick Landman, Gaurav Kumar Pandey, et al.
Cell Reports. Medicine|January 19, 2023
Genetic screens reveal new targetable vulnerabilities in BAP1-deficient mesotheliomaGaurav Kumar Pandey, Nick Landman, Hannah K Neikes, et al.
The Journal of Experimental Medicine|April 10, 2020
Combined deletion of Bap1, Nf2, and Cdkn2ab causes rapid onset of malignant mesothelioma in miceJitendra Badhai, Gaurav Kumar Pandey, Ji-Ying Song, et al.
Cancer Cell|December 18, 2014
The risk-associated long noncoding RNA NBAT-1 controls neuroblastoma progression by regulating cell proliferation and neuronal differentiationGaurav Kumar Pandey, Sanhita Mitra, Santhilal Subhash, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2019
EZH2 Is Overexpressed in <i>BRCA1</i>-like Breast Tumors and Predictive for Sensitivity to High-Dose Platinum-Based ChemotherapyJulian Puppe, Mark Opdam, Philip C Schouten, et al.
Pageof 2